Plasma homocysteine in the acute and convalescent phases after stroke
- PMID: 7740569
- DOI: 10.1161/01.str.26.5.795
Plasma homocysteine in the acute and convalescent phases after stroke
Abstract
Background and purpose: Stroke patients frequently manifest moderate hyperhomocysteinemia. In most published studies, plasma homocysteine was measured at least 1 month after stroke (or the interval was not reported). To determine whether plasma homocysteine concentrations change in the acute phase, we compared acute-phase values with both convalescent-phase and control values.
Methods: Plasma homocysteine concentrations were measured in the acute phase (mean, 2 days after stroke onset) in 162 first-ever stroke patients aged 50 years or more (median, 75 years) and again at a median interval of 583 days (range, 460 to 645 days) after stroke onset in a subgroup of 17 patients, with values for 60 age-matched subjects serving as controls. Twenty of the control subjects were reexamined 2 to 3 years after their initial examination.
Results: The median plasma homocysteine concentration was 13.4 mumol/L in the patient group compared with 13.8 mumol/L for control subjects (NS, Mann-Whitney U test) and increased from 11.4 mumol/L in the acute phase to 14.5 mumol/L in the convalescent phase in the subgroup of patients examined twice (P < .01, Wilcoxon signed rank test). In the 20 reexamined control subjects, no significant change over time in plasma homocysteine concentration was found.
Conclusions: The post-acute-phase increase in plasma homocysteine may explain why higher values were obtained for stroke patients than for control subjects in previous studies. Possible reasons for the variation in plasma homocysteine concentrations over time are (1) an acute-phase reduction secondary to a decrease in plasma albumin and (2) an increase in plasma homocysteine during the convalescent phase due to modified vitamin intake and/or lifestyle. The timing of plasma homocysteine measurements relative to stroke onset is a factor to be considered in the interpretation of results.
Comment in
-
Plasma homocysteine in ischemic stroke.Stroke. 1995 Dec;26(12):2374-5. Stroke. 1995. PMID: 7491671 No abstract available.
Similar articles
-
Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke.Stroke. 2001 Jan;32(1):57-62. doi: 10.1161/01.str.32.1.57. Stroke. 2001. PMID: 11136915 Clinical Trial.
-
Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.Stroke. 1996 Jun;27(6):1066-71. doi: 10.1161/01.str.27.6.1066. Stroke. 1996. PMID: 8650716
-
Marginal folate deficiency as a possible cause of hyperhomocystinaemia in stroke patients.Eur J Clin Chem Clin Biochem. 1997 Jan;35(1):25-8. doi: 10.1515/cclm.1997.35.1.25. Eur J Clin Chem Clin Biochem. 1997. PMID: 9156562
-
Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population.Invest Ophthalmol Vis Sci. 2014 Jun 6;55(7):4057-62. doi: 10.1167/iovs.14-14226. Invest Ophthalmol Vis Sci. 2014. PMID: 24906854
-
[Plasma homocysteine levels in patients with ischemic cerebral infarction].Med Clin (Barc). 1998 May 9;110(16):605-8. Med Clin (Barc). 1998. PMID: 9656197 Spanish.
Cited by
-
Homocysteine is associated with higher risks of ischemic stroke: A systematic review and meta-analysis.PLoS One. 2022 Oct 13;17(10):e0276087. doi: 10.1371/journal.pone.0276087. eCollection 2022. PLoS One. 2022. PMID: 36227950 Free PMC article.
-
Hyperhomocysteinemia and Ischemic Stroke: A Potential Dose-Response Association-A Systematic Review and Meta-analysis.TH Open. 2021 Sep 24;5(3):e420-e437. doi: 10.1055/s-0041-1735978. eCollection 2021 Jul. TH Open. 2021. PMID: 34595387 Free PMC article. Review.
-
Astaxanthin Protects PC12 Cells against Homocysteine- and Glutamate-Induced Neurotoxicity.Molecules. 2020 Jan 5;25(1):214. doi: 10.3390/molecules25010214. Molecules. 2020. PMID: 31948056 Free PMC article.
-
Serum Proteome Alterations in Human Cystathionine β-Synthase Deficiency and Ischemic Stroke Subtypes.Int J Mol Sci. 2019 Jun 25;20(12):3096. doi: 10.3390/ijms20123096. Int J Mol Sci. 2019. PMID: 31242583 Free PMC article.
-
GluN2A-NMDA receptor-mediated sustained Ca2+ influx leads to homocysteine-induced neuronal cell death.J Biol Chem. 2019 Jul 19;294(29):11154-11165. doi: 10.1074/jbc.RA119.008820. Epub 2019 Jun 5. J Biol Chem. 2019. PMID: 31167782 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous